Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$269.38
-1.3%
$275.38
$211.71
$329.72
$144.49B0.582.83 million shs1.79 million shs
Dow Inc. stock logo
DOW
DOW
$56.44
-0.9%
$57.27
$47.26
$60.69
$39.64B1.314.90 million shs7.08 million shs
The Coca-Cola Company stock logo
KO
Coca-Cola
$61.75
+0.3%
$60.07
$51.55
$64.69
$266.22B0.5914.03 million shs19.04 million shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
-1.33%+2.52%-4.40%-13.60%+12.81%
Dow Inc. stock logo
DOW
DOW
-0.95%-0.09%-1.10%+4.40%+7.34%
The Coca-Cola Company stock logo
KO
Coca-Cola
+0.32%+4.82%+1.95%+4.01%-2.83%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amgen Inc. stock logo
AMGN
Amgen
4.9225 of 5 stars
3.34.04.23.91.91.72.5
Dow Inc. stock logo
DOW
DOW
3.9953 of 5 stars
2.13.02.50.02.61.74.4
The Coca-Cola Company stock logo
KO
Coca-Cola
4.0809 of 5 stars
1.45.03.30.83.12.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amgen Inc. stock logo
AMGN
Amgen
2.53
Moderate Buy$296.9510.24% Upside
Dow Inc. stock logo
DOW
DOW
2.21
Hold$57.582.03% Upside
The Coca-Cola Company stock logo
KO
Coca-Cola
2.86
Moderate Buy$67.228.86% Upside

Current Analyst Ratings

Latest AMGN, KO, and DOW Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/19/2024
The Coca-Cola Company stock logo
KO
Coca-Cola
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$66.00 ➝ $65.00
4/17/2024
Amgen Inc. stock logo
AMGN
Amgen
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$314.00 ➝ $284.00
4/17/2024
Amgen Inc. stock logo
AMGN
Amgen
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$370.00 ➝ $360.00
4/12/2024
Amgen Inc. stock logo
AMGN
Amgen
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$320.00
4/12/2024
The Coca-Cola Company stock logo
KO
Coca-Cola
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$66.00 ➝ $68.00
4/10/2024
Dow Inc. stock logo
DOW
DOW
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$56.00 ➝ $60.00
4/3/2024
Amgen Inc. stock logo
AMGN
Amgen
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$329.00
4/2/2024
Dow Inc. stock logo
DOW
DOW
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$63.00 ➝ $68.00
3/28/2024
Amgen Inc. stock logo
AMGN
Amgen
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
3/1/2024
Dow Inc. stock logo
DOW
DOW
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoveragePeer Perform
2/14/2024
The Coca-Cola Company stock logo
KO
Coca-Cola
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$64.00 ➝ $66.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amgen Inc. stock logo
AMGN
Amgen
$28.19B5.13$25.95 per share10.38$11.65 per share23.12
Dow Inc. stock logo
DOW
DOW
$44.62B0.89$5.98 per share9.44$27.24 per share2.07
The Coca-Cola Company stock logo
KO
Coca-Cola
$45.75B5.82$3.01 per share20.50$6.36 per share9.71

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amgen Inc. stock logo
AMGN
Amgen
$6.72B$12.4921.5712.852.5523.83%154.27%10.95%5/2/2024 (Confirmed)
Dow Inc. stock logo
DOW
DOW
$589M$0.8268.8312.540.781.32%7.97%2.74%N/A
The Coca-Cola Company stock logo
KO
Coca-Cola
$10.71B$2.4824.9020.513.4623.42%42.50%11.92%4/30/2024 (Confirmed)

Latest AMGN, KO, and DOW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Amgen Inc. stock logo
AMGN
Amgen
$3.82N/A-$3.82N/AN/AN/A  
4/30/2024N/A
The Coca-Cola Company stock logo
KO
Coca-Cola
$0.70N/A-$0.70N/AN/AN/A  
4/25/2024Q1 24
Dow Inc. stock logo
DOW
DOW
$0.45$0.56+$0.11N/A$10.71 billion$10.77 billion    
2/13/202412/31/2023
The Coca-Cola Company stock logo
KO
Coca-Cola
$0.48$0.49+$0.01$0.52$10.68 billion$10.80 billion      
2/6/2024Q4 23
Amgen Inc. stock logo
AMGN
Amgen
$4.66$4.71+$0.05$8.00$8.13 billion$8.20 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amgen Inc. stock logo
AMGN
Amgen
$9.003.34%+10.01%72.06%12 Years
Dow Inc. stock logo
DOW
DOW
$2.804.96%N/A341.47%N/A
The Coca-Cola Company stock logo
KO
Coca-Cola
$1.943.14%+3.91%78.23%63 Years

Latest AMGN, KO, and DOW Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/11/2024
Dow Inc. stock logo
DOW
DOW
quarterly$0.704.9%5/30/20245/31/20246/14/2024
3/6/2024
Amgen Inc. stock logo
AMGN
Amgen
quarterly$2.253.25%5/16/20245/17/20246/7/2024
2/15/2024
The Coca-Cola Company stock logo
KO
Coca-Cola
quarterly$0.48503.27%3/14/20243/15/20244/1/2024
2/15/2024
Dow Inc. stock logo
DOW
DOW
quarterly$0.705.08%2/28/20242/29/20243/8/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amgen Inc. stock logo
AMGN
Amgen
10.14
1.65
1.13
Dow Inc. stock logo
DOW
DOW
0.78
1.77
1.16
The Coca-Cola Company stock logo
KO
Coca-Cola
1.29
1.13
0.95

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Amgen Inc. stock logo
AMGN
Amgen
76.50%
Dow Inc. stock logo
DOW
DOW
64.00%
The Coca-Cola Company stock logo
KO
Coca-Cola
70.26%

Insider Ownership

CompanyInsider Ownership
Amgen Inc. stock logo
AMGN
Amgen
0.46%
Dow Inc. stock logo
DOW
DOW
0.50%
The Coca-Cola Company stock logo
KO
Coca-Cola
0.97%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Amgen Inc. stock logo
AMGN
Amgen
26,700536.38 million533.91 millionOptionable
Dow Inc. stock logo
DOW
DOW
35,900702.29 million698.78 millionOptionable
The Coca-Cola Company stock logo
KO
Coca-Cola
79,1004.31 billion4.27 billionOptionable

AMGN, KO, and DOW Headlines

SourceHeadline
Bank Julius Baer & Co. Ltd Zurich Buys 64,648 Shares of The Coca-Cola Company (NYSE:KO)Bank Julius Baer & Co. Ltd Zurich Buys 64,648 Shares of The Coca-Cola Company (NYSE:KO)
marketbeat.com - April 25 at 8:21 PM
Coca-Cola (NYSE:KO) Trading Up 0.6%Coca-Cola (NYSE:KO) Trading Up 0.6%
marketbeat.com - April 25 at 7:07 PM
IS PepsiCo (PEP) a Better Buy Than Coca-Cola (KO) Post Earnings?IS PepsiCo (PEP) a Better Buy Than Coca-Cola (KO) Post Earnings?
stocknews.com - April 25 at 2:12 PM
Stay Ahead of the Game With Coke (KO) Q1 Earnings: Wall Streets Insights on Key MetricsStay Ahead of the Game With Coke (KO) Q1 Earnings: Wall Street's Insights on Key Metrics
zacks.com - April 25 at 10:20 AM
Have $500? 4 Absurdly Cheap Stocks Long-Term Investors Should Buy Right NowHave $500? 4 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now
fool.com - April 25 at 10:15 AM
Its Unlikely That The Coca-Cola Companys (NYSE:KO) CEO Will See A Huge Pay Rise This YearIt's Unlikely That The Coca-Cola Company's (NYSE:KO) CEO Will See A Huge Pay Rise This Year
finance.yahoo.com - April 25 at 9:48 AM
Fanta Says, Do More of What You Wanta With New Global CampaignFanta Says, 'Do More of What You Wanta' With New Global Campaign
prnewswire.com - April 25 at 8:33 AM
Is Coca-Cola a No-Brainer Dividend Stock to Buy While Its Below $65?Is Coca-Cola a No-Brainer Dividend Stock to Buy While It's Below $65?
fool.com - April 25 at 8:05 AM
RBC Capital Reaffirms Their Buy Rating on Coca-Cola (KO)RBC Capital Reaffirms Their Buy Rating on Coca-Cola (KO)
markets.businessinsider.com - April 25 at 4:47 AM
Coca-Cola Europacific Partners plc Announces Q1 Trading Update & Interim Dividend DeclarationCoca-Cola Europacific Partners plc Announces Q1 Trading Update & Interim Dividend Declaration
accesswire.com - April 25 at 2:00 AM
Members Capital Advisors Inc. Sells 33,447 Shares of The Coca-Cola Company (NYSE:KO)Members Capital Advisors Inc. Sells 33,447 Shares of The Coca-Cola Company (NYSE:KO)
marketbeat.com - April 24 at 10:52 PM
Coca-Cola (KO) Exceeds Market Returns: Some Facts to ConsiderCoca-Cola (KO) Exceeds Market Returns: Some Facts to Consider
zacks.com - April 24 at 6:51 PM
Coca-Cola (NYSE:KO) Stock Price Up 0.3%Coca-Cola (NYSE:KO) Stock Price Up 0.3%
marketbeat.com - April 24 at 4:22 PM
3 High-Yielding Dividend Stocks That Can Help Bankroll Your Retirement Years3 High-Yielding Dividend Stocks That Can Help Bankroll Your Retirement Years
fool.com - April 24 at 10:45 AM
The corporate conversation around AI is changing: Morning BriefThe corporate conversation around AI is changing: Morning Brief
finance.yahoo.com - April 24 at 8:45 AM
Coca-Cola vs. Pepsi: Which is a better stock pick for 2024?Coca-Cola vs. Pepsi: Which is a better stock pick for 2024?
finbold.com - April 24 at 4:59 AM
Schnieders Capital Management LLC Sells 16,855 Shares of The Coca-Cola Company (NYSE:KO)Schnieders Capital Management LLC Sells 16,855 Shares of The Coca-Cola Company (NYSE:KO)
marketbeat.com - April 23 at 11:25 PM
Coca-Cola (NYSE:KO)  Shares Down 0.1% Coca-Cola (NYSE:KO) Shares Down 0.1%
marketbeat.com - April 23 at 2:58 PM
Coca-Cola expects significant benefits from generative AI partnership with MicrosoftCoca-Cola expects significant benefits from generative AI partnership with Microsoft
msn.com - April 23 at 12:41 PM
How Much Will Coca-Cola Pay in Dividends This Year?How Much Will Coca-Cola Pay in Dividends This Year?
fool.com - April 23 at 11:21 AM
Coca-Cola (KO) Earnings Expected to Grow: What to Know Ahead of Next Weeks ReleaseCoca-Cola (KO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
zacks.com - April 23 at 11:07 AM
Here is What to Know Beyond Why CocaCola Company (The) (KO) is a Trending StockHere is What to Know Beyond Why CocaCola Company (The) (KO) is a Trending Stock
zacks.com - April 23 at 10:06 AM
The 7 Best Positioned Dow Stocks for April 2024The 7 Best Positioned Dow Stocks for April 2024
investorplace.com - April 23 at 9:59 AM
The Coca-Cola Company and Microsoft announce five-year strategic partnership to accelerate cloud and generative AI initiativesThe Coca-Cola Company and Microsoft announce five-year strategic partnership to accelerate cloud and generative AI initiatives
prnewswire.com - April 23 at 9:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Amgen logo

Amgen

NASDAQ:AMGN
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
DOW logo

DOW

NYSE:DOW
Dow Inc., through its subsidiaries, engages in the provision of various materials science solutions for packaging, infrastructure, mobility, and consumer applications in the United States, Canada, Europe, the Middle East, Africa, India, the Asia Pacific, and Latin America. The company operates through Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings segments. The Packaging & Specialty Plastics segment provides ethylene, and propylene and aromatics products; and polyethylene, polyolefin elastomers, ethylene vinyl acetate, and ethylene propylene diene monomer rubbers for mobility and transportation, consumer, wire and cable, and construction end-markets. The Industrial Intermediates & Infrastructure segment offers purified ethylene, ethylene and ethanol amines, propylene glycol and polyether polyols, aromatic isocyanates and coatings, adhesives, sealants, elastomers, and composites. This segment also provides caustic soda, and ethylene dichloride and vinyl chloride monomers; and cellulose ethers, redispersible latex powders, and acrylic emulsions. The Performance Materials and Coatings segment provides architectural paints and coatings, and industrial coatings that are used in maintenance and protective industries, wood, metal packaging, traffic markings, thermal paper, and leather; and silicon metal, siloxanes, and intermediates used as key materials in manufacturing differentiated downstream silicone products. It also engages in property and casualty insurance, as well as reinsurance business. Dow Inc. was incorporated in 2018 and is headquartered in Midland, Michigan.
Coca-Cola logo

Coca-Cola

NYSE:KO
The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.